Y Tomiyama
Overview
Explore the profile of Y Tomiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
171
Citations
1647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akuta K, Kashiwagi H, Yujiri T, Nishiura N, Morikawa Y, Kato H, et al.
J Thromb Haemost
. 2018 Nov;
17(1):206-219.
PMID: 30388316
Essentials Acquired Glanzmann thrombasthenia (aGT) is generally caused by function-blocking antibodies (Abs). We demonstrated a unique aGT case due to marked reduction of αIIbβ3 with anti-αIIbβ3 Abs. The anti-αIIbβ3 Abs...
2.
Kato H, Nakayama T, Uruma M, Okuyama Y, Handa M, Tomiyama Y, et al.
Vox Sang
. 2014 Dec;
108(3):243-50.
PMID: 25536173
Background And Objectives: This study compares the frequency of adverse transfusion reactions (ATRs) after first transfusions with the frequency of ATRs for subsequent (non-first) transfusions. Materials And Methods: Five hospitals...
3.
Kodama T, Hikita H, Kawaguchi T, Shigekawa M, Shimizu S, Hayashi Y, et al.
Cell Death Differ
. 2012 Jul;
19(11):1856-69.
PMID: 22790873
Anti-apoptotic Bcl-2 family proteins, which inhibit the mitochondrial pathway of apoptosis, are involved in the survival of various hematopoietic lineages and are often dysregulated in hematopoietic malignancies. However, their involvement...
4.
Tomiyama Y, Miyakawa Y, Okamoto S, Katsutani S, Kimura A, Okoshi Y, et al.
J Thromb Haemost
. 2012 Mar;
10(5):799-806.
PMID: 22409309
Background: Eltrombopag is an oral, non-peptide thrombopoietin receptor agonist that has shown efficacy and safety in chronic immune thrombocytopenia (ITP). However, ethnic differences in eltrombopag exposure have been reported: area...
5.
Schipperus M, Fijnheer R, Pabinger I, Godeau B, Michel M, Tomiyama Y, et al.
Vox Sang
. 2011 Nov;
102(3):261-8.
PMID: 22050204
No abstract available.
6.
Tazumi A, Negoro M, Tomiyama Y, Misawa N, Itoh K, Moore J, et al.
Br J Biomed Sci
. 2011 Apr;
68(1):19-22.
PMID: 21473257
Polymerase chain reaction (PCR) amplification was performed on 20 isolates of five Campylobacter species using a degenerate primer pair designed in silico to generate a product of the luxS gene...
7.
Kamae T, Kiyomizu K, Nakazawa T, Tadokoro S, Kashiwagi H, Honda S, et al.
J Thromb Haemost
. 2011 Feb;
9(5):1040-8.
PMID: 21342433
Background: Thromboxane A(2) receptor (TXA(2)R) abnormality appears to dominantly disturb platelet function. Objectives: To reveal a molecular genetic defect in a patient with TXA(2)R abnormality and investigate the mechanism for...
8.
Akiyama M, Kashiwagi H, Todo K, Moroi M, Berndt M, Kojima H, et al.
J Thromb Haemost
. 2009 Jun;
7(8):1373-83.
PMID: 19522742
Background: Glycoprotein (GP)VI deficiency is a rare platelet disorder with a mild bleeding tendency. However, its pathophysiology remains unclear. Objectives: We characterized a novel GPVI-deficient patient with immune thrombocytopenic purpura...
9.
Maesaki S, Hashiguchi K, Tomiyama Y, Sasaki E, Miyazaki H, Miyazaki Y, et al.
Nihon Kokyuki Gakkai Zasshi
. 2008 Jan;
37(11):875-9.
PMID: 18217308
We measured the plasma concentration of itraconazole (ITCZ) in 18 patients who received ITCZ for the treatment of pulmonary aspergilloma. Abnormal laboratory values were observed in 4 out of 10...
10.
Kamae T, Shiraga M, Kashiwagi H, Kato H, Tadokoro S, Kurata Y, et al.
J Thromb Haemost
. 2006 May;
4(6):1379-87.
PMID: 16706985
Objective: Platelet integrin alpha(IIb)beta3 plays a crucial role in platelet aggregation, and the affinity of alpha(IIb)beta3 for fibrinogen is dynamically regulated. Employing modified ligand-binding assays, we analyzed the mechanism by...